Introduction {#eji4400-sec-0010}
============

The autosomal‐dominant hyper‐IgE syndrome (HIES) is a rare primary immunodeficiency caused by dominant‐negative mutations in STAT3 [1](#eji4400-bib-0001){ref-type="ref"}, [2](#eji4400-bib-0002){ref-type="ref"}. Associated multisystem features include eczema, delayed shedding of primary teeth, bone fractures, typical facial characteristics, craniosynostosis, and vascular abnormalities. Classical laboratory findings are increased serum IgE levels, low percentage of T~H~17 cells, reduced memory B cells and blood eosinophilia [3](#eji4400-bib-0003){ref-type="ref"}.

STAT3‐deficient HIES patients are particularly susceptible to mucocutaneous candidiasis and recurrent skin and respiratory infections with a rather narrow spectrum of pathogens, in particular *Staphylococcus aureus* (*S. aureus*), *Streptococcus pneumoniae* (*S*. *pneumoniae*), and *Haemophilus influenzae* (*H. influenzae*) [3](#eji4400-bib-0003){ref-type="ref"}. Postinfectious pneumatoceles are pathognomonic, but patients also frequently develop bronchiectasis. These lung complications facilitate secondary opportunistic infections and have a major impact on morbidity and mortality in HIES [4](#eji4400-bib-0004){ref-type="ref"}. Therefore, it seems essential to understand both the particular susceptibility to infection as well as the associated increased tissue destruction in HIES.

A major immunological hallmark of STAT3‐deficient HIES is the lack of IL‐17--producing T~H~ cells (T~H~17) [5](#eji4400-bib-0005){ref-type="ref"}, [6](#eji4400-bib-0006){ref-type="ref"}. T~H~17 cytokines augment the production of chemokines and antimicrobial peptides, particularly from keratinocytes and bronchial epithelial cells. Thus, the lack of T~H~17 may lead to deficient neutrophil recruitment and reduced antimicrobial killing in local infections, thereby offering an explanation for the observed susceptibility to mucocutaneous and tissue infections [7](#eji4400-bib-0007){ref-type="ref"}. Whereas T~H~17 immunity has been closely linked to mucocutaneous candidiasis, invasive lung infections with *S*. *aureus*, like in HIES, are not typical for other primary immunodeficiencies with reduced IL‐17 signaling [8](#eji4400-bib-0008){ref-type="ref"}. Furthermore, it was recently shown that STAT3‐deficient patients with somatic mosaicism and a normal T~H~17 response may still develop mucocutaneous candidiasis as well as pneumonia [9](#eji4400-bib-0009){ref-type="ref"}. These observations imply that the lack of T~H~17 alone is not sufficient to explain the specific susceptibility to staphylococcal lung infections in STAT3‐deficient HIES. Defects in neutrophil function have been suggested to underlie the particular susceptibility to staphylococcal abscesses and lung infections and candidiasis [10](#eji4400-bib-0010){ref-type="ref"}, [11](#eji4400-bib-0011){ref-type="ref"}, [12](#eji4400-bib-0012){ref-type="ref"}. In particular, altered chemotaxis has been reported repeatedly [11](#eji4400-bib-0011){ref-type="ref"}, [12](#eji4400-bib-0012){ref-type="ref"}, [13](#eji4400-bib-0013){ref-type="ref"}, [14](#eji4400-bib-0014){ref-type="ref"}, [15](#eji4400-bib-0015){ref-type="ref"}. However, published data are inconsistent and variations even within the same patient have been observed [14](#eji4400-bib-0014){ref-type="ref"}, [15](#eji4400-bib-0015){ref-type="ref"}, [16](#eji4400-bib-0016){ref-type="ref"}, [17](#eji4400-bib-0017){ref-type="ref"}, [18](#eji4400-bib-0018){ref-type="ref"}. In a recent study, STAT3‐deficient neutrophils were found to migrate into blisters, indicating normal chemotaxis in HIES in vivo [9](#eji4400-bib-0009){ref-type="ref"}. Although there might be temporary variations in the chemotactic capacity of STAT3‐deficient neutrophils [13](#eji4400-bib-0013){ref-type="ref"}, the heterogeneity of findings, and the lack of correlation with *S*. *aureus* infections or disease severity in individual patients [15](#eji4400-bib-0015){ref-type="ref"} challenges a direct causal relationship between impaired neutrophil chemotaxis and the clinical phenotype in HIES.

Overall, the discrepant data on neutrophil function in autosomal‐dominant HIES is puzzling. Studies performed prior to the discovery of STAT3 deficiency as the genetic cause of HIES (2007) may be confounded by inclusion of patients with other causes of hyper‐IgE syndrome. Another explanation for the variable results may be methodological differences in neutrophil function analysis. Density gradient centrifugation, the most commonly employed procedure for neutrophil isolation, leads to a minor contamination with eosinophils due to overlapping densities and thus to a mixed granulocyte preparation [19](#eji4400-bib-0019){ref-type="ref"}. As eosinophil numbers are very low in healthy controls, their presence in these granulocyte preparations is usually considered negligible. However, the influence of increased eosinophil numbers in HIES patients has not been assessed. As eosinophils contain an arsenal of toxic substances that are released during incubation with *S. aureus* [20](#eji4400-bib-0020){ref-type="ref"}, [21](#eji4400-bib-0021){ref-type="ref"}, it is essential to understand their contribution to the clinical phenotype and functional neutrophil testing in HIES.

Here, we report an enhanced in vitro neutrophil cell death in STAT3‐deficient HIES patients as compared to healthy controls. Our data suggest that both the presence of eosinophils and reduced STAT3 signaling affect neutrophil cell death kinetics and are associated with increased *S. aureus*‐induced cell death.

Results {#eji4400-sec-0020}
=======

Variable clinical severity despite similar laboratory findings in STAT3‐deficient HIES patients {#eji4400-sec-0030}
-----------------------------------------------------------------------------------------------

The study cohort comprised six male and two female STAT3‐deficient HIES patients between two and thirty years of age at the time of study inclusion (Table [1](#eji4400-tbl-0001){ref-type="table"}). Clinical laboratory findings retrieved from the patient charts showed typical immunological alterations found in STAT3‐deficient HIES patients [3](#eji4400-bib-0003){ref-type="ref"}, such as elevated IgE levels, low or absent T~H~17 cells/IL‐17 levels, reduced percentages of marginal zone B cells and/or class‐switched memory B cells (Table [1](#eji4400-tbl-0001){ref-type="table"}). Blood neutrophil numbers were normal in six patients, but were occasionally below normal limits in HIES \#1 and in HIES \#5. Eosinophilia, i.e. elevated eosinophil counts in blood (\> 500 cells/μL), was documented in seven patients (Table [1](#eji4400-tbl-0001){ref-type="table"}). The investigated patients consistently showed relatively elevated eosinophil numbers in granulocyte preparations, including the patient with normal absolute eosinophil counts in whole blood. An exception was patient \#8, who had a very high percentage of eosinophils in the granulocyte fraction (40%) during the initial analysis, but not at a subsequent analysis (2.5%).

###### 

Laboratory findings and demographic details of the study cohort

  Patient‐ID                                                                 HIES \#1                                                                                                                HIES \#2                                                                                                       HIES \#3                                                                                                                   HIES \#4                                                                                             HIES \#5                                                                                           HIES \#6                                                               HIES \#7                                                               HIES \#8
  -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------
  Age                                                                        11 years                                                                                                                12 years                                                                                                       15 years                                                                                                                   16 years                                                                                             4 years                                                                                            26 years                                                               30 years                                                               2 years
  Gender                                                                     Male                                                                                                                    Female                                                                                                         Male                                                                                                                       Male                                                                                                 Male                                                                                               Female                                                                 Male                                                                   Male
  Mutation                                                                   H332L                                                                                                                   R382L                                                                                                          T622I                                                                                                                      K340E                                                                                                R382W                                                                                              Y657C                                                                  R382L                                                                  D371_G380del
  Localisation of Mutation                                                   DNA‐binding domain                                                                                                      DNA‐binding domain                                                                                             SH2 domain                                                                                                                 DNA‐binding domain                                                                                   DNA‐binding domain                                                                                 SH2‐binding domain                                                     DNA‐binding domain                                                     DNA‐binding domain
  Age at first symptoms                                                      Newborn period                                                                                                          Newborn period                                                                                                 Newborn period                                                                                                             Newborn period                                                                                       8 weeks                                                                                            Newborn period                                                         6 months                                                               3 months
  First clinical symptom of HIES                                             Newborn eczema                                                                                                          Newborn eczema                                                                                                 Newborn eczema                                                                                                             Newborn eczema/impetigo                                                                              Superinfected eczema                                                                               Infected eczema                                                        Skin abscesses                                                         Skin abscesses
  Age when HIES was first suspected                                          7 years                                                                                                                 1 year                                                                                                         6 years                                                                                                                    5 years                                                                                              3 years                                                                                            19 years                                                               2 years                                                                6 months
  Which symptom led to investigation for HIES?                               Recurrent abscesses and herpes zoster                                                                                   Recurrent purulent otitis, eczema, cold abscesses                                                              Pleuropneumonia and pneumatocele, elevated IgE                                                                             Recurrent pulmonary infections, skin eczema                                                          Recurrent skin infections and otitis                                                               Recurrent abscesses, skin infections                                   Abscesses                                                              Skin abscess
  Medical care in immunological clinic?                                      Since age 7 years                                                                                                       Since age 7 years                                                                                              Since age 6 years                                                                                                          Since age 15 years                                                                                   Since age 3 years                                                                                  Since age 20 years                                                     Since age 18 years                                                     Since age 6 months
  Documented neutrophil numbers                                              Some normal but also several low values (range 577--1270/μL)                                                            Normal                                                                                                         Normal                                                                                                                     Normal                                                                                               Generally normal, some low values (range 740--990/μL)                                              Normal                                                                 Normal                                                                 Normal
  Eosinophil numbers (highest documented value)                              352/μL                                                                                                                  800/μL                                                                                                         800/μL                                                                                                                     790/μL                                                                                               3180/μL                                                                                            2500/μL                                                                1400/μL                                                                2200/μL
  Exemplary % eosinophils among granulocytes documented during experiments   19%                                                                                                                     23%                                                                                                            10%                                                                                                                        19%                                                                                                  27%                                                                                                17%                                                                    20%                                                                    40%
  IgE (highest documented value)                                             1040 kU/L                                                                                                               4101 kU/L                                                                                                      17 081 kU/L                                                                                                                9965 kU/L                                                                                            1997 kU/L                                                                                          12 640 kU/L                                                            36 000 kU/L                                                            4270 kU/L
  IgG, IgA, IgM                                                              Normal                                                                                                                  Normal                                                                                                         Not determined                                                                                                             Normal                                                                                               Normal                                                                                             Normal                                                                 Normal                                                                 Normal [41](#eji4400-bib-0041){ref-type="ref"}
  Protein specific antibodies                                                Anti‐tetanus after booster: normal                                                                                      Anti‐tetanus after booster: absent; anti‐MMR after booster: normal                                             Anti‐tetanus, anti‐measles and anti‐varicella: detectable                                                                  Anti‐diphtheria and anti‐tetanus after booster: absent; anti‐mumps: absent                           Anti‐tetanus after booster: absent                                                                 Anti‐diphtheria: normal; Anti‐tetanus: low                             Anti‐tetanus: normal                                                   Anti‐tetanus: low; anti‐haemophilus: low
  Anti‐pneumococcal antibodies                                               Partial positive vaccination titres                                                                                     Partial positive vaccination titres                                                                            Partial positive vaccination titres                                                                                        Low                                                                                                  Not performed                                                                                      Low                                                                    Normal                                                                 Normal
  T~H~17 cells/IL‐17 formation                                               Almost absent (0.04% CD3+CD4+IL‐17+ cells)                                                                              Almost absent (0.01% CD4+CD45RO+IL‐17+ cells)                                                                  Almost absent (0.07% CD3+CD4+IL‐17+ cells)                                                                                 Low (0.2% CD3+CD4+IL‐17+ cells)                                                                      Low (0.27% CD4+CD45RO+ IL‐17+ cells)                                                               Low IL‐17 release from PBMCs [35](#eji4400-bib-0035){ref-type="ref"}   Low IL‐17 release from PBMCs [35](#eji4400-bib-0035){ref-type="ref"}   LOW (0.5‐1% CXCR‐CCR4+CCR6+) [41](#eji4400-bib-0041){ref-type="ref"}
  B cell differentiation                                                     Slightly low percentage of marginal zone B cells (4.28%), reduced percentage of class‐switched memory B cells (2.92%)   Low percentage of marginal zone B cells (3.78%), normal percentage of class‐switched memory B cells (5.81%).   Low marginal zone B cells (3.61%), almost complete lack of CD27^+^IgD^+^ and class‐switched CD27^+^IgD^−^ memory B cells   Low percentage of marginal zone B cells (3.95%) and very low class‐switched memory B cells (0.96%)   Low numbers of marginal zone B cells (4.03%) and of class‐switched CD27^+^IgD^−^ B cells (2.13%)   Not performed                                                          Not performed                                                          Low levels of marginal zone B cells (2%) and switched memory B cells (0.5--1%) [41](#eji4400-bib-0041){ref-type="ref"}
  FOX P3 expression                                                          Normal                                                                                                                  Normal                                                                                                         Normal                                                                                                                     Normal                                                                                               Not performed                                                                                      Not performed                                                          Not performed                                                          Not performed

DNA, deoxyribonucleic acid; FOX P3, forkhead box P3; HIES, autosomal‐dominant hyper‐IgE syndrome; IL‐17, Interleukin‐17; MMR, measles, mumps, rubella; SH2, Src Homology 2; \[\] = literature reference.

**Reference values**:‐ Neutrophil numbers were considered normal if they were \> 1500/ μL.

‐ Eosinophilia (i.e. elevated blood eosinophil counts) was considered if eosinophil numbers were \> 500/μL.

‐ Markers to detect TH17 cells varied. Internal reference values from full‐aged, healthy individuals without STAT3 mutations as provided by the performing laboratory are as follows: CD3+CD4+IL‐17+ cells: 0.38‐3.1%. CD4+CD45RO+IL‐17+ cells: 1.1--4.76%. CXCR‐CCR4+CCR6+ cells: 3.8--5.6%.

John Wiley & Sons, Ltd.

The severity of clinical symptoms was highly variable between the patients, even in those with identical mutations (Table [2](#eji4400-tbl-0002){ref-type="table"}). All patients had a history of fungal infections. *S. aureus* was isolated from various body sites in seven of eight patients. Available clinical histology results revealed presence of neutrophils in abscesses of three patients and in the bronchoalveolar lavage (BAL) fluid of two patients. Furthermore, eosinophils were present in one BAL fluid sample and in three histological samples (Table [2](#eji4400-tbl-0002){ref-type="table"}, Supporting Information Fig. [1](#eji4400-supl-0001){ref-type="supplementary-material"}).

###### 

Clinical presentation and complications

  Patient‐ID                                                                                    HIES \#1                                                                                                                                   HIES \#2                                                                                                     HIES \#3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   HIES \#4                                                                                                                                                                                          HIES \#5                                                                                                                                                                                                                                                                 HIES \#6                             HIES \#7                                                  HIES \#8
  --------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------ --------------------------------------------------------- --------------------------------------------------------
  Pneumonia                                                                                     Recurrent obstructive bronchitis/pneumonia below the age of 2 years                                                                        ARDS due to RSV‐pneumonia requiring ventilation at age of 5 months. Pneumonia at age 1, 2, 9, and 14 years   8 pneumonia (at age 4, 6, 7, 9, 10, and 15 years), 2 times with isolation of *H. influenzae*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               6--7 pneumonia/year between age 0--5 years, 1 pneumonia/year since age 5 years, overall over 30 episodes                                                                                          None                                                                                                                                                                                                                                                                     None                                 1 pneumonia at age 30 years                               None
  Skin abscesses                                                                                recurrent abscesses various locations: armpit, groin, antecubital fossa, buttocks                                                          twice (forehead, forearm)                                                                                    twice (buttocks, axilla)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   six times (knee, eyelids)                                                                                                                                                                         superinfected eczema, recurrent panaritia                                                                                                                                                                                                                                recurrent, location not documented   once, location not documented                             recurrent, first time at age 3 months (*S. aureus*)
  Abscesses of inner organs                                                                     Lymph node abscess                                                                                                                         None                                                                                                         Lung abscess requiring drainage and subsequent resection of upper lung lobe                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Not documented                                                                                                                                                                                    Lymph node abscess, due to *Streptococcus pyogenes*                                                                                                                                                                                                                      Not documented                       Not documented                                            No
  Other abscesses and skin infections                                                           Recurrent panaritia                                                                                                                        Abscess of labium                                                                                            Dental abscess requiring tooth extraction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Not documented                                                                                                                                                                                    Not documented                                                                                                                                                                                                                                                           Hip joint                            Not documented                                            No
  Otitis media                                                                                  Recurrent, up to \> 10/year. Chronic purulent otitis at age 2 years. Mastoiditis due to *S. pneumonia* and *S*. *aureus* at age 3 years.   Recurrent otitis. Documented colonization with *Pseudomonas aeruginosa*                                      Once                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Once                                                                                                                                                                                              5--6 episodes/year at age 2 and 3 years                                                                                                                                                                                                                                  Yes, recurrent                       Not documented                                            No
  Specific viral infections                                                                     Severe varicella at age 6 months, once herpes zoster                                                                                       Varicella infection                                                                                          H1N1‐Infection with central pneumonia and *P. aeruginosa* colonization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     No                                                                                                                                                                                                No                                                                                                                                                                                                                                                                       No                                   No                                                        No
  Positive *S. aureus* findings                                                                 Isolated from otorrhea                                                                                                                     Isolated from abscesses, recurrent colonization with MRSA                                                    Once documented in bronchoalveolar lavage, skin colonization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Skin colonization                                                                                                                                                                                 Skin colonization                                                                                                                                                                                                                                                        Documented from skin, nose, throat   Not documented                                            Isolated from abscesses
  Positive *S. pneumoniae* findings                                                             Not documented                                                                                                                             Not documented                                                                                               Sputum                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Once in bronchoalveolar lavage                                                                                                                                                                    Lymph node abscess                                                                                                                                                                                                                                                       Yes, recurrent                       Not documented                                            Not documented
  Positive fungal findings                                                                      Oral candidiasis, nail mycosis                                                                                                             Genital candidiasis, nail mycosis, oral candidiasis                                                          Oral candidiasis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Tinea pedis, nail mycosis                                                                                                                                                                         Oral candidiasis                                                                                                                                                                                                                                                         Nails                                *Aspergillus*, *Candida* and *Scedosporium* in the lung   Oral candidiasis; A*spergillus* in the nasopharynx
  Positive *Haemophilus influenzae* findings                                                    Not documented                                                                                                                             Sputum                                                                                                       Twice during pneumonia, once during bronchitis (sputum)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Not documented                                                                                                                                                                                    Once during otitis                                                                                                                                                                                                                                                       Yes, recurrent                       Yes                                                       Once in nasopharynx during acute respiratory infection
  Positive *Pseudomonas aeruginosa* findings                                                    Not documented                                                                                                                             Recurrently documented during otitis                                                                         Only colonization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Colonization                                                                                                                                                                                      Not documented                                                                                                                                                                                                                                                           No                                   Chronic colonization of the lungs                         No
  Pneumatocele                                                                                  No                                                                                                                                         Yes                                                                                                          Yes (left and right lung)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Yes (right lung)                                                                                                                                                                                  No                                                                                                                                                                                                                                                                       No                                   No                                                        No
  Bronchiectasis                                                                                No                                                                                                                                         No                                                                                                           Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Yes                                                                                                                                                                                               No                                                                                                                                                                                                                                                                       No                                   Yes, progressive                                          No
  Clubbed fingers/hippocratic nails                                                             No                                                                                                                                         No                                                                                                           No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Yes                                                                                                                                                                                               No                                                                                                                                                                                                                                                                       No                                   No                                                        No
  Bronchoalveolar lavage (BAL)‐results (as documented by the diagnostic pathology department)   Not performed                                                                                                                              No growth                                                                                                    During pneumonia: numerous neutrophils, lymphocytes and some macrophages, sparse S*. aureus*, very few eosinophils. Numerous degenerative transformed macrophages and neutrophils.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Prior to lung resection: numerous granulocytes, no bacteria. After lung resection: S.*pneumoniae*, numerous granulocytes, numerous squamous epithelia.                                            Not performed                                                                                                                                                                                                                                                            Not performed                        Not performed                                             Not performed
  Histology (as documented by the diagnostic pathology department)                              Lymph node abscess: granulocytic absceding inflammation with histiocytic reaction                                                          Skin biopsy: inflammatory infiltration of lymphatic and histiocytic cells                                    Dental abscess: phlegmonous inflammation with presence of numerous neutrophils, some lymphocytes and plasma cells, few eosinophils (Supporting Information Fig. [1A](#eji4400-supl-0001){ref-type="supplementary-material"}). Lung abscess: purulent, absceding pneumonia with massive numbers of alveolar macrophages, histiocytes, neutrophils, cell detritus. On the edges, fibrinoid connective tissue with overall fewer cells, but several eosinophils, plasma cells and neutrophils. In bronchia: cell detritus, foam cell macrophages and neutrophils (Supporting Information Fig. [1B](#eji4400-supl-0001){ref-type="supplementary-material"}).   Lung resection (not during acute infection): findings are compatible with multiple past pneumonia. No significant eosinophilia, no granuloma, no acute purulent infection, no fungal infection.   Lymph node aspiration: immature suppurative granuloma reaction. Multiple eosinophils in the granuloma center (Supporting Information Fig. [1C](#eji4400-supl-0001){ref-type="supplementary-material"} and [D](#eji4400-supl-0001){ref-type="supplementary-material"}).   Not performed                        Not performed                                             Pyogenic granuloma on the tongue

ARDS, acute respiratory distress syndrome; RSV, respiratory syncytial virus.

**The data in this table was retrieved from patient charts and/or questionnaire**.

John Wiley & Sons, Ltd.

The patients received symptomatic treatment including antimicrobial prophylaxis, abscess drainage, and IgG‐substitution when needed, but also lung surgery in three patients (data not shown).

Basic neutrophil functions were not altered in STAT3‐deficient HIES patients {#eji4400-sec-0040}
----------------------------------------------------------------------------

Several neutrophil functions were tested (Table [3](#eji4400-tbl-0003){ref-type="table"}). Due to limitations in sample size and availability not all tests could be performed for every patient. Reactive oxygen species (ROS)‐release, chemotaxis, and adhesion were normal in the patients tested. Early whole blood and neutrophil‐mediated staphylococcal killing was similar between investigated patients and controls. Neutrophils from patients released neutrophil extracellular traps (NETs) upon phorbol 12‐myristate 13‐acetate (PMA) stimulation (Supplement Movie 1--2, Supporting Information Figs. [2‐4](#eji4400-supl-0001){ref-type="supplementary-material"}). In summary, STAT3‐deficient HIES patients in our cohort did not show substantial alterations in basic neutrophil functions.

###### 

Assessed neutrophil functions

  Patient‐ID                           HIES \#1   HIES \#2   HIES \#3   HIES \#4   HIES \#5   HIES \#6   HIES \#7   HIES \#8
  ------------------------------------ ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------------------------------------------------
  Neutrophil chemotaxis                Normal     n.p.       Normal     n.p.       n.p.       n.p.       n.p.       n.p.
  Neutrophil adhesion                  Normal     n.p.       Normal     n.p.       n.p.       n.p.       n.p.       n.p.
  Quantitative NET formation           Normal     Normal     Normal     Normal     Normal     n.p.       n.p.       n.p.
  ROS release upon PMA stimulation     Normal     Normal     Normal     n.p.       Normal     n.p.       n.p.       Normal [41](#eji4400-bib-0041){ref-type="ref"}
  Whole blood‐killing of *S. aureus*   Normal     Normal     n.p.       n.p.       Normal     Normal     Normal     Normal
  Neutrophil‐killing of *S. aureus*    n.p.       Normal     n.p.       n.p.       n.p.       Normal     Normal     Normal

n.p., test not performed; \[\], literature reference.

John Wiley & Sons, Ltd.

Cell death kinetics were accelerated in neutrophils from STAT3‐deficient HIES patients {#eji4400-sec-0050}
--------------------------------------------------------------------------------------

Quantification of cell death by flow cytometry (Fig. [1](#eji4400-fig-0001){ref-type="fig"}A--C) revealed accelerated cell death of STAT3‐deficient neutrophils compared to concomitantly analyzed control cells (Fig. [1](#eji4400-fig-0001){ref-type="fig"}D). In particular, increased early apoptosis (intact cell membrane) (Fig. [1](#eji4400-fig-0001){ref-type="fig"}E) was found at four and nine hours after cell isolation and enhanced late apoptosis/necrosis (permeabilized cell membrane) (Fig. [1](#eji4400-fig-0001){ref-type="fig"}F) was evident at nine and fourteen hours. Interindividual differences were observed in both patients and controls. The percentage of eosinophils at the time of initial measurement, i.e. four hours after cell isolation, correlated strongly with the percentage of late apoptotic/necrotic neutrophils at four hours (*r* = 0.92; *p* = 0.0002) (Supporting Information Fig. [5](#eji4400-supl-0001){ref-type="supplementary-material"}). A less significant correlation (*r* = 0.65; *p* = 0.0418) was observed with the percentage of early apoptotic neutrophils at four hours. There was, however, no correlation with the percentage of eosinophils at later time points for any of the cell death categories. Cytokine stimulation with IL‐8 increased cell viability throughout the observation time (Fig. [1](#eji4400-fig-0001){ref-type="fig"}G, Supporting Information Fig. [6](#eji4400-supl-0001){ref-type="supplementary-material"}). Still, a substantial difference in cell death remained discernible between patients and controls for both early apoptosis (Fig. [1](#eji4400-fig-0001){ref-type="fig"}H) and late apoptosis/necrosis (Fig. [1](#eji4400-fig-0001){ref-type="fig"}I) at nine and fourteen hours. Increased cell viability and reduced early apoptosis in combination with maintained differences in cell death between patient and control cells were also found for a limited number of samples treated with G‐CSF and GM‐CSF (Supporting Information Fig. [7](#eji4400-supl-0001){ref-type="supplementary-material"}). The enhanced cell death kinetics in HIES patients compared to controls were also observed during visual comparison of granulocyte suspensions by microscopy (Supporting Information Fig. [2C](#eji4400-supl-0001){ref-type="supplementary-material"} and [D](#eji4400-supl-0001){ref-type="supplementary-material"}, Supporting Information Fig. [8](#eji4400-supl-0001){ref-type="supplementary-material"}) and during live cell imaging (Supplement Movie 3--6).

![Accelerated cell death kinetics of neutrophils from STAT3‐deficient HIES patients. Granulocytes were isolated from STAT3‐deficient HIES patients and concomitant control samples followed by cytokine or vehicle stimulation. At designated time points (four, nine, and fourteen hours), equal amounts of the samples were stained with Annexin V and Dapi and analyzed by flow cytometry (detailed gating strategy see Supporting Fig. [11](#eji4400-supl-0001){ref-type="supplementary-material"}). (**A--C**) displays the same dataset highlighting the gating strategy for the identification of the following cell death categories according to the respective Annexin V and Dapi staining: (A) viable (Annexin V**^−^** Dapi**^−^**), (B) early apoptotic (Annexin V**^+^** Dapi**^−^**) and (C) late apoptotic/necrotic (Annexin V**^+^** Dapi**^+^**) neutrophils. Primary necrotic (Annexin V**^−^** Dapi**^+^**) neutrophils are not displayed since no significant differences were found. (D--I) Quantitative data showing the percentages of (D, G) viable, (E, H) early apoptotic and (F, I) late apoptotic/necrotic neutrophils after stimulation with (D--F) vehicle or (G--I) Il‐8. (D--I) Data are shown as mean ± SD and are pooled from four (D--F) and three (G--I) independent experiments, respectively. Each patient was matched to the concomitant daily control. Matched samples are displayed with the same symbol (dark symbols = HIES patients; light symbols = controls). RM (repeated measures) two‐way Anova with Bonferroni‐Analysis for multiple comparison was used for statistical analysis (*p* \> 0.05 = not significant (ns); *p* ≤ 0.05 = \*; *p* \< 0.01 = \*\*; *p* \< 0.001 = \*\*\*; *p* \< 0.0001 = \*\*\*\*).](EJI-48-1975-g001){#eji4400-fig-0001}

*S. aureus‐*induced cell death was increased in STAT3 deficiency and upon addition of eosinophils {#eji4400-sec-0060}
-------------------------------------------------------------------------------------------------

*S. aureus* is a major pathogen in STAT3‐deficient HIES. We therefore analyzed the impact of *S. aureus* on neutrophil cell death in vitro. Both granulocyte preparations and highly purified neutrophils from STAT3‐deficient patients consistently showed increased spontaneous and *S. aureus‐*induced lytic cell death as compared to concomitantly analyzed control cells (Fig. [2](#eji4400-fig-0002){ref-type="fig"}A--D). When purified neutrophils were supplemented with 20% eosinophils *S. aureus*‐induced cell death increased, both in cells from patients and controls (Fig. [2](#eji4400-fig-0002){ref-type="fig"}E). Due to sample size limitations the data shown in Figure [2](#eji4400-fig-0002){ref-type="fig"} could not be pooled for statistics. However, to verify the effect of STAT3 inhibition and eosinophil supplementation on lactate dehydrogenase (LDH) release, the experiments were repeated with cells from healthy donors employing a chemical STAT3 inhibitor (ST18).

![Augmented spontaneous and *S*. *aureus‐*induced lytic cell death in STAT3‐deficient HIES patients. Eosinophils and neutrophils were purified by magnetic cell separation from granulocyte suspensions of STAT3‐deficient HIES patients and concomitant healthy controls. LDH release was measured in supernatants five hours after costimulation of various granulocyte fractions (original granulocyte suspension, highly purified neutrophils, purified neutrophils + 20% purified eosinophils) with vcl (vehicle = medium) or *S*. *aureus* WT (MOI 5). Due to limitations in cell availability not all conditions could be performed in every experiment. (A--D) Three individual experiments are shown, including cells from four different HIES patients and their concomitant controls. Depicted is the mean with SD of at least two sample replicates. B+D were performed at the same time point and contain the same controls. (E) The effect of supplementation of neutrophils with eosinophils on S. *aureus*‐induced cell lysis for available samples in A--C is shown. Data are pooled from three independent experiments.](EJI-48-1975-g002){#eji4400-fig-0002}

In contrast to cells isolated from HIES patients, chemical STAT3 inhibition of control granulocytes or purified neutrophils alone did not substantially affect spontaneous lytic cell death (Fig. [3](#eji4400-fig-0003){ref-type="fig"}A and B, Supporting Information Fig. [9C](#eji4400-supl-0001){ref-type="supplementary-material"}). However, in line with the observations from primary cells from STAT3‐deficient patients, ST18‐treated cells showed significantly augmented LDH release upon challenge with *S. aureus*. Similar to the observation obtained from patient samples, the supplementary lytic effect imposed by eosinophils during staphylococcal infection was also present in healthy controls (Fig. [3](#eji4400-fig-0003){ref-type="fig"}A). When evaluating whether presence of eosinophils during granulocyte isolation in healthy controls affected the LDH release, a mild correlation was observed for the percentage of eosinophils within the granulocyte fraction and the LDH release of DMSO‐treated granulocytes stimulated with vehicle or *S. aureus* (Supporting Information Fig. [9A](#eji4400-supl-0001){ref-type="supplementary-material"} and B). The correlation was lost after preincubation with ST18, which led to a significant increase in LDH upon *S. aureus* challenge (Supporting Information Fig. [9C](#eji4400-supl-0001){ref-type="supplementary-material"}).

![Increased *S*. *aureus‐*induced lytic cell death in STAT3‐inhibited cells. Eosinophils and neutrophils were purified by magnetic cell separation from healthy control granulocyte suspensions. The original granulocyte suspension and/or purified neutrophils were incubated for 60 min with 20 μM ST18 (STAT3 Inhibitor XVIII, BP‐1‐102) or DMSO. Subsequently, cells were washed and coincubated with vcl (vehicle = medium), *S*. *aureus* WT and/or *S. aureus agr* ^−^ (both MOI 5) for five hours. (A) LDH release after stimulation of purified STAT3‐inhibited (ST18) and control (DMSO) neutrophils with/without supplementation of 20% eosinophils with vcl or *S. aureus* WT for five hours is shown. Displayed are pooled results from eight independent experiments with cells from nine different controls. (B) LDH release following stimulation of STAT3‐inhibited (ST18) and control (DMSO) granulocytes with vcl, *S*. *aureus* WT, or *S. aureus agr* **^−^** (both MOI 5) for five hours is shown. Displayed are pooled results from four independent experiments with cells from eight different controls. (C) IL‐8 release of STAT3‐inhibited (ST18) and control (DMSO) granulocytes following stimulation with vcl, *S*. *aureus* WT, or *agr*‐ (both MOI 5) for five hours is shown. Displayed are pooled results from three independent experiments with six different controls (detection limit 3.1 pg/mL). Statistical analysis A--C: Depicted is the mean with SD. RM (repeated measures) two‐way Anova with Bonferroni‐Analysis for multiple comparison was used for statistical analysis for A--C (*p* \> 0.05 = not significant (ns); *p* ≤ 0.05 = ~\*~; *p* \< 0.01 = ~\*\*~; *p* \< 0.001 = ~\*\*\*;~ *p* \< 0.0001 = ~\*\*\*\*~).](EJI-48-1975-g003){#eji4400-fig-0003}

The staphylococcal agr‐system influences cell lysis during STAT3 inhibition {#eji4400-sec-0070}
---------------------------------------------------------------------------

Secreted virulence factors such as hemolysins and leukocidins have been implicated in mediating the lytic effect of *S. aureus* on eosinophils and neutrophils [21](#eji4400-bib-0021){ref-type="ref"}, [22](#eji4400-bib-0022){ref-type="ref"}. Therefore, we studied whether the expression of secreted virulence factors was essential for the observed cell lysis in STAT3‐inhibited samples. Granulocytes from healthy blood donors were stimulated with either an *agr* **^+^** wild type *S. aureus* strain (8325‐4 \[WT\]) or its isogenic *agr* ^−^ mutant (WA250 \[*agr* ^−^\]) in the presence or absence of STAT3 inhibitor. The *agr* ^−^ strain is characterized by reduced expression of α‐, β‐, δ‐, and γ‐hemolysins, leukocidins, enterotoxins, and TSST‐1 [23](#eji4400-bib-0023){ref-type="ref"}. Challenge with the *agr* ^−^ strain diminished LDH release in both STAT3‐inhibited and control samples (Fig. [3](#eji4400-fig-0003){ref-type="fig"}B). The highest cell lysis was observed in STAT3‐inhibited samples treated with wild type bacteria expressing the *agr* gene regulator.

STAT3 inhibition in granulocytes does not affect the release of IL‐1β, TNF‐α, or IL‐8 by *S. aureus* {#eji4400-sec-0080}
----------------------------------------------------------------------------------------------------

Different cytokines implicated in cell death were analyzed in supernatants of STAT3‐inhibited and control granulocytes following incubation with WT and *agr* ^−^ *S. aureus*. IL‐1β or TNF‐α were not detected in any of the samples (three independent experiments with six different controls, detection limit IL‐1β 3.9 pg/mL, TNF‐α 15.6 pg/mL). However, IL‐8 production was more pronounced when stimulated with the *agr* ^−^ in comparison to the WT strain (Fig. [3](#eji4400-fig-0003){ref-type="fig"}C). Still, IL‐8 production did not differ significantly between STAT3‐inhibited and control samples.

Discussion {#eji4400-sec-0090}
==========

STAT3‐deficient HIES patient are strikingly susceptible to acquire staphylococcal infections and suffer from enhanced tissue destruction following pulmonary infections. So far, this specific susceptibility remains incompletely understood. Given the role of neutrophils in the defense against *S. aureus* and *Candida*, a specific dysfunction in STAT3‐deficient neutrophils would offer a logical solution [11](#eji4400-bib-0011){ref-type="ref"}, [12](#eji4400-bib-0012){ref-type="ref"}, [13](#eji4400-bib-0013){ref-type="ref"}. However, in agreement with other recent studies we found normal superoxide production [1](#eji4400-bib-0001){ref-type="ref"}, [3](#eji4400-bib-0003){ref-type="ref"}, [24](#eji4400-bib-0024){ref-type="ref"}, chemotaxis [3](#eji4400-bib-0003){ref-type="ref"}, and preserved staphylococcal killing [1](#eji4400-bib-0001){ref-type="ref"}. Moreover, tissue samples and BAL fluid from our patients revealed presence of neutrophils during infections, thus underscoring functional chemotaxis, despite low or absent IL‐17 signaling. This observation and the maintained infectious phenotype of STAT3‐deficient individuals with somatic mosaicism and a normal T~H~17 compartment [9](#eji4400-bib-0009){ref-type="ref"} suggest that additional factors are crucial for their susceptibility to infection.

The majority of HIES patients present with eosinophilia, which was also true for seven of our eight patients. However, even in the absence of blood eosinophilia, the percentage of eosinophils among isolated granulocytes was generally elevated in patients. Analyzed neutrophil cell death kinetics in vitro were accelerated in HIES patients in the presence of high eosinophil numbers in the granulocyte preparations. This effect was attributable to both enhanced early apoptosis and late apoptosis/necrosis. As the percentage of eosinophils correlated only at initial time points with the percentage of early apoptotic and late apoptotic/necrotic neutrophils, eosinophilia may most likely only partly explain the accelerated cell death kinetics seen in vitro. Because apoptotic neutrophils are functionally impaired in vitro [25](#eji4400-bib-0025){ref-type="ref"}, accelerated cell death may become relevant in vivo, particularly during infections when neutrophil survival is prolonged by cytokines. Consistent with our findings, it was previously reported that STAT3‐deficient neutrophils showed enhanced proinflammatory cytokine expression, yet, without the expected associated apoptosis delay [1](#eji4400-bib-0001){ref-type="ref"}. In our hands, patient neutrophils responded with delayed apoptosis to IL‐8, GM‐CSF, and G‐CSF. Yet, cell death was still clearly enhanced when compared to control neutrophils, particularly at late time points. The partially maintained anti‐apoptotic properties are probably related to residual STAT3 signaling in affected individuals, as well as alternative signaling pathways [26](#eji4400-bib-0026){ref-type="ref"}, [27](#eji4400-bib-0027){ref-type="ref"}, [28](#eji4400-bib-0028){ref-type="ref"}.

Given the relevance of *S. aureus* infections in HIES patients, we assessed how stimulation with *S. aureus* would affect neutrophil fate in the presence of STAT3 deficiency and eosinophils. In the limited number of available samples we observed that granulocytes and purified neutrophils from STAT3‐deficient HIES patients showed an increased baseline of spontaneous cell lysis and were more sensitive to *S. aureus‐*induced lytic cell death than the respective control cells. Supplementation of purified neutrophils with eosinophils led to higher *S. aureus‐*induced lytic cell death in both HIES patients and controls. This suggests that the observed accelerated cell death rate in the context of high levels of eosinophils in vitro may also play a role in staphylococcal infections. In our cohort, eosinophils were documented in three histological samples and one BAL obtained during acute infections. Others have reported on eosinophilic infiltrations in the lung, skin or abscesses in individuals with STAT3‐deficient HIES [24](#eji4400-bib-0024){ref-type="ref"}, [29](#eji4400-bib-0029){ref-type="ref"}. Interestingly, eosinophils appear to be particularly susceptible to cell lysis and degranulation when incubated with *S. aureus* [20](#eji4400-bib-0020){ref-type="ref"}, [21](#eji4400-bib-0021){ref-type="ref"}. In our experiments employing eosinophil supplementation to control neutrophils, increased cell lysis became evident when stimulating with *S. aureus*. Therefore, local eosinophilia could potentially limit antimicrobial efficacy of neutrophils during manifest infection.

The use of a chemical STAT3 inhibitor allowed assessing the functional consequences of STAT3 deficiency in the absence of high numbers of eosinophils during sample preparation. While STAT3 inhibition alone did not increase cell lysis, there was a significant augmentation of *S. aureus‐*induced lytic cell death in STAT3‐inhibited cells. The initial concentration of eosinophils did only mildly correlate with cell lysis of granulocytes and the correlation was completely lost after STAT3‐inhibition. This suggests that reduced STAT3 signaling in neutrophils may negatively affect cell survival during staphylococcal infection, independent of eosinophilia.

It has been argued that increased neutrophil lysis by certain *S. aureus* strains favors pathogen survival and augments disease severity in otherwise healthy individuals [30](#eji4400-bib-0030){ref-type="ref"}. The staphylococcal quorum sensing agr‐operon activates transcription and production of virulence factors that may destroy neutrophils [22](#eji4400-bib-0022){ref-type="ref"}. We demonstrate that the effect of reduced STAT3 signaling on cell death is most pronounced in the presence of secreted staphylococcal virulence factors present in the *agr* ^+^ wild type strain. Enhanced anti‐apoptotic IL‐8 induction may partly explain the protection from cell death during incubation with the toxin‐deficient *agr* ^−^ mutant. Yet, this does not appear to be relevant for the observed differences in cell death during deficient STAT3 signalling, as IL‐8 expression did not differ between STAT3‐inhibited and control samples. The precise mechanism underlying the increased *S. aureus*‐induced cell lysis in STAT3 deficiency remains to be elucidated. Nevertheless, our findings may be clinically relevant, as a recent study showed that HIES patients are frequently colonized with highly virulent and antibiotic‐resistant *S. aureus* strains [31](#eji4400-bib-0031){ref-type="ref"}.

STAT3 is ubiquitously expressed. Thus, the specific infection susceptibility in HIES at mucocutaneous sites, is likely shaped by both immune and epithelial cells. Potential epithelial factors include altered cytokine expression and deficient release of antimicrobial factors [32](#eji4400-bib-0032){ref-type="ref"}, [33](#eji4400-bib-0033){ref-type="ref"}, [34](#eji4400-bib-0034){ref-type="ref"}. Together with impaired IL‐17 formation [7](#eji4400-bib-0007){ref-type="ref"}, [35](#eji4400-bib-0035){ref-type="ref"} these factors could lead to a higher bacterial load at the infection site. In this setting, STAT3‐deficient neutrophils that respond with increased cell lysis to virulent *S. aureus* may further impair infection control and contribute to tissue destruction. Maintained neutrophil functionality in HIES, however, seems to be sufficient to prevent invasive organ and blood stream infections.

Our results also offer an explanation for the controversial literature on neutrophil functions (e.g. chemotaxis) in HIES. Density gradient centrifugation with subsequent erythrocyte lysis is the most widely used method for rapid isolation of neutrophils [30](#eji4400-bib-0030){ref-type="ref"}, [36](#eji4400-bib-0036){ref-type="ref"}, [37](#eji4400-bib-0037){ref-type="ref"}. Red blood cell lysis with ammonium chloride is beneficial for maintenance of neutrophil properties [37](#eji4400-bib-0037){ref-type="ref"}, but may impair eosinophil viability and induce eosinophil degranulation [38](#eji4400-bib-0038){ref-type="ref"}, [39](#eji4400-bib-0039){ref-type="ref"}. While this effect may be negligible in donors with low eosinophil contamination, a high eosinophil percentage in granulocyte preparations, as in HIES, negatively affects neutrophil viability and may then alter neutrophil function analysis, particularly if analysis is delayed [40](#eji4400-bib-0040){ref-type="ref"}.

Limitations of our study include the restricted number of patients and that not all experiments could be performed for each patient due to limited clinical material. Yet, despite interindividual variability our results were consistent. Moreover, the effect of eosinophil supplementation and STAT3 inhibition was reproducible in healthy controls. Still, the small sample size impedes correlating experimental findings with disease severity in individual patients. Furthermore, although neutrophils and eosinophils were detected in histological samples from our patients, their interaction in vivo may be affected by additional factors, which are not present during in vitro testing. It would be particular interesting to further evaluate how the specific milieu induced in STAT3‐deficient lung epithelium may alter the host‐pathogen interactions and affect postinfectious tissue remodeling.

In summary, we describe eight unrelated STAT3‐deficient HIES patients with variable clinical presentation and overall normal basic neutrophil functions in vitro, in spite of staphylococcal infections and mucocutaneous candidiasis. Histological samples in individual patients indicate that neutrophils are recruited to infected tissues, even though IL‐17 formation is impaired. Our data suggest that both STAT3 deficiency and the presence of eosinophils negatively affect neutrophil cell death kinetics, which may hamper in vitro neutrophil function testing in STAT3‐deficient patients. The presence of eosinophils in abscesses from HIES‐patients and the observed increased *S. aureus*‐induced cell lysis in presence of eosinophils and STAT3 deficiency offer the possibility that this effect may also be relevant during infections. Further investigations are needed to decipher the precise molecular mechanisms behind this observation and to assess whether increased *S*. *aureus*‐induced cell death in the presence of STAT3 deficiency or eosinophilia affects pathogen control and tissue destruction in vivo.

Materials and methods {#eji4400-sec-0100}
=====================

Study cohort and ethics {#eji4400-sec-0110}
-----------------------

The study included eight patients with genetically confirmed STAT3‐deficient HIES at the Centre of Chronic Immunodeficiency, Freiburg, Germany or at the Karolinska University Hospital Stockholm, Sweden. Ethical approval was obtained by local ethical committees. All patients or their legal guardians gave informed consent for participation and data collection. Clinical data were retrieved from questionnaires filled in by patients or their parents, and by reviewing patient charts. Patients \#6 and \#7 participated earlier in another study [35](#eji4400-bib-0035){ref-type="ref"}. Details on patient \#8 were reported previously [41](#eji4400-bib-0041){ref-type="ref"}. Blood samples from healthy controls were obtained either anonymously from the blood bank, or following informed consent from unaffected relatives, laboratory or hospital staff. For experiments requiring eosinophils, blood samples were also obtained from healthy donors without infectious history, but with supposedly asthmatic or allergic predisposition not requiring current medication, following informed consent. Here, sample blood volume was increased to 80 mL to achieve sufficient eosinophil numbers for experiments.

Granulocyte isolation and purification of neutrophils and eosinophils {#eji4400-sec-0120}
---------------------------------------------------------------------

Blood samples were processed within three hours after blood draw using a standard protocol for neutrophil isolation [36](#eji4400-bib-0036){ref-type="ref"}, [37](#eji4400-bib-0037){ref-type="ref"}. Each patient sample was accompanied by a concomitant control sample. Samples were processed via density gradient centrifugation with isotonic Biocoll with 10 mm hydroxyethyl‐piperazineethane‐sulfonic acid buffer (HEPES) (density of 1.077 g/mL, Biochrom). Red cells were lysed with lysis buffer containing ammonium chloride, potassium hydrogen carbonate, and ethylenediaminetetraacetic acid (EDTA) (PH 7.4) at 4°C, followed by washes in PBS and final suspension in medium, i.e. sterile‐filtered RPMI‐1640 (without Phenolred, endotoxin tested; Sigma‐Aldrich) + 2% human albumin (Albunorm 20%, Octapharma) unless otherwise indicated. Viability and purity of the obtained granulocytes was routinely ≥ 95% as assessed by trypan blue staining and flow cytometry, respectively. In healthy controls, contamination of granulocytes with eosinophils was usually \< 7%. For selected experiments, granulocytes were further purified into neutrophils and eosinophils employing the EasySep Human Neutrophil Enrichment kit (Stemcell) and the EasySep Human Eosinophil Enrichment kit (Stemcell), generally achieving a purity ≥ 99% for neutrophils and ≥ 94% for eosinophils (Verification of cell origin see Supporting Information Fig. [10A--F](#eji4400-supl-0001){ref-type="supplementary-material"}). In order to highlight the differences between the preparations, we use the term *granulocytes* when referring to the initial isolation product and *neutrophils* when further purification steps were employed.

Bacterial strains {#eji4400-sec-0130}
-----------------

We used *S. aureus* strain 8325‐4 (WT) and its isogenic *agr*‐mutant WA250 (*agr* ^−^) with known lower toxin and enzyme expression [23](#eji4400-bib-0023){ref-type="ref"}.

Granulocyte cell death kinetics by flow cytometry {#eji4400-sec-0140}
-------------------------------------------------

Granulocytes were stimulated with medium (vehicle = vcl) or cytokines (IL‐8, G‐CSF, GM‐CSF; PeproTech or R&D Systems). At designated time points, equal cell numbers were stained with Annexin V (BD Bioscience) and 4′, 6‐diamidino‐2‐phenylindole dihydrochloride (Dapi, Life Technologies) to detect apoptotic and necrotic cells, respectively. The following categories were employed: early apoptotic (Annexin V**^+^** Dapi**^−^**) and late apoptotic/necrotic (Annexin V**^+^** Dapi**^+^**), primary necrotic (Annexin V**^−^** Dapi**^+^**) and viable (Annexin V**^−^** Dapi**^−^**) neutrophils. For gating strategy see Supporting Information Fig. [11](#eji4400-supl-0001){ref-type="supplementary-material"}. Neutrophils were generally distinguished from eosinophils by means of their different autofluorescence, e.g. in FL3 (excitation 488 nm; emission filter 620/30) versus FL4 (excitation 488 nm; emission filter 695/30). Samples were analyzed on a Gallios flow cytometer (Beckman Coulter). No additional antibodies were used during cell death assessment. Cell type origin in the autofluorescent gates was confirmed in separate experiments (Supporting Information Fig. [10D--F](#eji4400-supl-0001){ref-type="supplementary-material"}). Flowcytometric data was analyzed with Kaluza software (Beckman Coulter).

Lytic cell death determination by LDH release {#eji4400-sec-0150}
---------------------------------------------

In order to assess spontaneous and *S. aureus‐*induced lytic cell death, various granulocyte fractions (original granulocyte suspension, purified neutrophils and/or purified neutrophils + 20% eosinophils) were incubated with vehicle (medium)*, S. aureus* WT and/or *agr* ^−^ mutant at a multiplicity of infection (MOI) of five for five hours at 37°C, 5% CO2. After two hours, gentamicin (final concentration 200 μg/mL) was added to kill off extracellular bacteria. After centrifugation the obtained supernatant was used for analysis of LDH and cytokines. LDH release was measured with the Cytotoxicity Detection Kit^PLUS^ (Roche) according to the manufacturer\'s instructions.

STAT3 inhibition of neutrophils from healthy controls {#eji4400-sec-0160}
-----------------------------------------------------

Granulocytes or purified neutrophils were incubated for one hour with the STAT3 Inhibitor XVIII, BP‐1‐102 (Calbiochem) here named ST18, at a concentration of 20 μM (Supporting Information Figs. [12](#eji4400-supl-0001){ref-type="supplementary-material"} and [13](#eji4400-supl-0001){ref-type="supplementary-material"}) or DMSO diluted in medium as vehicle control, followed by two washes with PBS. Subsequently, spontaneous and *S. aureus‐*induced lytic cell death of various granulocyte fractions was determined as described above.

Measurement of cytokines {#eji4400-sec-0170}
------------------------

IL‐8, IL‐1beta, and TNF‐alpha were measured in supernatants obtained after five hour incubation of STAT3‐inhibited or DMSO‐treated control granulocytes with medium (vcl), *S. aureus* WT or *agr* ^−^ employing commercial ELISA‐kits (BD Bioscience OptEIA ELISA kits).

NET quantification and visualization {#eji4400-sec-0180}
------------------------------------

Granulocytes were seeded in black 96‐well plates and stimulated with vehicle or 25 nM phorbol 12‐myristate 13‐acetate (PMA, Sigma Aldrich) at 37°C, 5% CO2 for 2.5 hours. Then, the cell impermeable DNA staining dye Sytox green (Invitrogen) was added and fluorescence signal was detected with a fluorescent reader. NET formation was visually confirmed by fluorescence microscopy (Supporting Information Fig. [2](#eji4400-supl-0001){ref-type="supplementary-material"}). In selected experiments, granulocytes were stained with CellTracker™ dye (Invitrogen) prior to stimulation. Following two hours of stimulation, Sytox green was added and the plate was analyzed with an automated fluorescence microscope (Olympus Scan\^R) (Supporting Information Figs. [3](#eji4400-supl-0001){ref-type="supplementary-material"} and [4](#eji4400-supl-0001){ref-type="supplementary-material"}).

Staphylococcal killing assay {#eji4400-sec-0190}
----------------------------

Fifty microliters whole blood and/ or 2 × 10^5^ granulocytes in RPMI‐1640 + 2% human albumin were incubated with serum‐opsonized *S. aureus* (2 × 10^5^ cfu, MOI 1) at 37°C, 5% CO~2~, 130 rpm. After 30 and 120 minutes cells were lysed with 0.1% Saponin and bacterial counts were determined via serial dilution plating.

Neutrophil function tests: ROS, chemotaxis, and adhesion {#eji4400-sec-0200}
--------------------------------------------------------

Basic neutrophil function tests were performed as previously described [42](#eji4400-bib-0042){ref-type="ref"}. In brief, PMA‐induced release of ROS was determined by lucigenin chemiluminescence assay. For the adhesion assay, Calcein‐AM (Life Technologies) stained cells were stimulated with vehicle, Pam3Cys (Invitrogen), n‐formyl‐L‐methionyl‐leucine‐phenylalanine (fMLP), PMA, or LPS (all Sigma Aldrich) for 30 minutes, then washed and lysed, followed by detection of fluorescence intensity. For chemotaxis, Calcein‐AM stained cells were seeded in Fluoroblok‐inserts (BD Falcon). Chemotactic substances such as fMLP, platelet activating factor (PAF), and C5a (all Sigma Aldrich) were pipetted onto the plate bottoms and chemotaxis of cells from the upper insert to the bottom was determined by measuring fluorescence intensity over 45 minutes. Due to limitations in the availability and size of patient samples, not all tests could be performed for every patient.

Statistics {#eji4400-sec-0210}
----------

Statistical analysis was performed using GraphPad Prism 7. Patient and concomitant control samples and in vitro treated control samples were matched and analyzed with repeated measures (RM) two‐way Anova with Bonferroni‐Analysis for multiple comparison. Statisical analysis was only performed if ≥ three sample sets were available. Correlation was estimated using Pearson correlation.
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agr
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